Company Highlights

All
Announcements
Press Releases
In The News

Announcement
Integrated Nanotherapeutics is presenting at Breakthrough T1D Clinical & Research Congress 2026, October 9-11, in Philadelphia, PA.

October 1, 2026

Announcement
Integrated Nanotherapeutics will be partnering at RESI Boston 2026, Sept 22-23, in Boston, MA.

September 8, 2026

Announcement
Integrated Nanotherapeutics is invited to exhibit at World Health Expo (WHX) Osaka 2026, July 2-4, in Osaka, Japan.

June 22, 2026

Announcement
Integrated Nanotherapeutics welcomes Dr. Carmella Evans-Molina to the Scientific Advisory Board.

June 18, 2026

Announcement
Integrated Nanotherapeutics will be partnering at BIO International 2026, June 22-25, in San Diego, CA.

June 10, 2026

Announcement
Integrated Nanotherapeutics will be exhibiting at Web Summit 2026, May 11-14, in Vancouver, BC.

May 6, 2026

Announcement
Integrated Nanotherapeutics will be speaking at the 21st Immunology of Diabetes Society Congress & Australian Islet Study Group Meeting (IDS) 2026, Apr 20-24, in Brisbane, Australia.

April 20, 2026

Announcement
Integrated Nanotherapeutics will be speaking at the 9th Antigen-Specific Immune Tolerance Summit (ASIT) 2026 Annual Meeting, Mar 3-6, in Boston.

March 3, 2026

Announcement
Integrated Nanotherapeutics will be attending Biotech Showcase 2026 during JPM Week, Jan 13 – 15, in San Francisco.

January 12, 2026

Announcement
Integrated Nanotherapeutics will be speaking at the 8th Antigen-Specific Immune Tolerance Summit (ASIT) 2025, Feb 25 – 27, in Boston.

February 25, 2025

Announcement
Integrated Nanotherapeutics will be attending Biotech Showcase 2025 during JPM Week, Jan 13 – 15, in San Francisco.

January 15, 2025